BEXIMCO

IFIC

Beximco industry

Beximco Pharmaceuticals Ltd. is a leading manufacturer and exporter of pharmaceuticals in Bangladesh, forming an integral part of the Beximco Group, one of the largest conglomerates in the country. Established in 1976, the company has grown to become a key player in the pharmaceutical industry, not only within Bangladesh but also in international markets, exporting its products to more than 50 countries across the globe.

History

The inception of Beximco Pharmaceuticals Ltd. traces back to 1976, shortly after the independence of Bangladesh, when the country was in dire need of developing its own industrial base for economic development. The founders of the Beximco Group, Salman F Rahman and Sohail F Rahman, envisioned a company that could meet the healthcare needs of the Bangladeshi population while also contributing to the national economy through exports.

Operations

Beximco Pharmaceuticals operates from a state-of-the-art manufacturing facility located in Dhaka, Bangladesh, designed to produce a wide range of pharmaceutical products adhering to global standards. The company's product portfolio includes generics for a variety of therapeutic areas, including but not limited to, anti-infectives, cardiovascular, antidiabetics, respiratory, and oncology drugs. Beximco Pharmaceuticals is also known for its pioneering efforts in introducing new drug delivery systems to the Bangladeshi market.

Research and Development

A significant part of Beximco Pharmaceuticals' success can be attributed to its strong focus on Research and Development (R&D). The company invests heavily in R&D to not only improve existing products but also to innovate new products and drug delivery systems. This commitment to innovation ensures that Beximco Pharmaceuticals remains at the forefront of the pharmaceutical industry in Bangladesh.

International Presence

Beximco Pharmaceuticals' international operations are a testament to its commitment to quality and excellence. The company has made significant inroads into highly regulated markets such as the United States, Europe, and Australia, among others. This global presence not only serves as a revenue stream but also enhances the company's reputation on the international stage.

Corporate Social Responsibility

As part of the larger Beximco Group, Beximco Pharmaceuticals is deeply committed to corporate social responsibility (CSR). The company's CSR initiatives focus on healthcare, education, and social development, aiming to make a positive impact on the communities it serves.

Challenges and Future Prospects

Like any other pharmaceutical company, Beximco Pharmaceuticals faces challenges such as regulatory hurdles, competition from both local and international players, and the need for continuous innovation. However, with its strong foundation, commitment to quality, and focus on R&D, Beximco Pharmaceuticals is well-positioned to continue its growth trajectory and expand its footprint in the global pharmaceutical market.

‎